OM
OMDA.US Omada Health, Inc. Common Stock
- Market cap
- USD 889M
- P/E
- 35.8x
- P/B
- 3.25x
- ROE
- 4.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is OMDA.US undervalued?
Graham numberOMDA.US trades 127.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Omada Health, Inc. Common Stock fundamental analysis
No fundamental analysis for Omada Health, Inc. Common Stock yet.
Omada Health, Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Omada Health, Inc. Common Stock
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. I…
Full company profileOmada Health, Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Omada Health, Inc. Common Stock annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 89.2M | 123M | 170M | 260M | 343M |
| Gross Profit | 42.8M | 70.0M | 103M | 171M | 242M |
| Operating Income | -72.4M | -66.0M | -43.7M | -12.0M | 4.78M |
| EBITDA | -64.0M | -58.4M | -37.8M | -4.75M | 12.2M |
| Net Income | -72.5M | -67.5M | -47.1M | -12.8M | 11.8M |
| EPS | -1.30 | -1.21 | -0.85 | -0.22 | 0.18 |
| Balance Sheet | |||||
| Total Assets | 222M | 175M | 151M | 305M | 349M |
| Total Liabilities | 66.2M | 76.2M | 86.3M | 75.7M | 75.4M |
| Shareholders' Equity | 156M | 98.9M | 64.6M | 230M | 273M |
| Cash & Short-term Investments | 168M | 116M | 76.4M | 222M | 243M |
| Total Debt | 30.8M | 30.6M | 30.2M | - | - |
| Cash Flow | |||||
| Operating Cash Flow | -69.0M | -49.7M | -34.2M | 18.3M | 9.75M |
| Capital Expenditure | 2.72M | 2.92M | 3.86M | 1.32M | 4.45M |
| Free Cash Flow | -71.7M | -52.7M | -38.0M | 16.9M | 5.30M |
| Ratios | |||||
| ROE | -46.6% | -68.2% | -72.9% | -5.6% | 4.3% |
| ROA | -32.7% | -38.6% | -31.2% | -4.2% | 3.4% |
| Net Profit Margin | -81.3% | -55.0% | -27.8% | -4.9% | 3.5% |
| Debt to Equity | 0.20x | 0.31x | 0.47x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Omada Health, Inc. Common Stock dividends
Omada Health, Inc. Common Stock has not paid dividends in the last 4 fiscal years.
Who owns Omada Health, Inc. Common Stock
- Insiders 2.28%
- Institutions 89.39%
- Public & others 8.33%
- Shares outstanding 62.0M
- Free float 51.9M
Top funds holding OMDA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| American Century Small Cap Growth Inv | 2.78M | 4.48% | -1.22% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.80M | 2.90% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.20M | 1.94% | 0.00% | Oct 2026 |
| Oberweis Micro-Cap | 1.01M | 1.63% | 0.00% | Jun 2026 |
| Fidelity Growth Company Fund | 1.01M | 1.62% | 0.00% | Aug 2026 |
| Loomis Sayles Small Cap Growth Instl | 917K | 1.48% | 0.00% | Sep 2026 |
| Nuveen Quant Small Cap Equity R6 | 497K | 0.80% | +1.63% | Sep 2026 |
| iShares Russell 2000 Growth ETF | 448K | 0.72% | -0.38% | Oct 2026 |
| Fidelity Small Cap Index | 390K | 0.63% | 0.00% | Aug 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 330K | 0.53% | +0.43% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 284K | 0.46% | +0.24% | Oct 2026 |
| Vanguard Russell 2000 ETF | 278K | 0.45% | +35.69% | Sep 2026 |
| VALIC Company I Small Cap Growth | 271K | 0.44% | -1.33% | Sep 2026 |
| Fidelity Extended Market Index | 251K | 0.40% | +490.60% | Sep 2026 |
| Fidelity Growth Company K6 | 249K | 0.40% | 0.00% | Aug 2026 |
| Vanguard Explorer Inv | 243K | 0.39% | +48.31% | Sep 2026 |
| CREF Total Global Stock Account R3 | 206K | 0.33% | -1.87% | Sep 2026 |
| Stt Strt® SPDR® S&P®HlthCrSvcsETF | 179K | 0.29% | 0.00% | Oct 2026 |
| Nuveen Quant Small/Mid Cap Eq R6 | 167K | 0.27% | +3.87% | Sep 2026 |
| Schroder Global Healthcare A Acc | 160K | 0.26% | 0.00% | Sep 2026 |
Top institutions holding OMDA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Revelation Capital Management, LLC | 4.86M | 7.84% | -6.72% | Jun 2026 |
| Divisadero Street Capital Management, LP | 3.80M | 6.13% | -35.46% | Jun 2026 |
| American Century Companies Inc | 3.70M | 5.96% | +0.47% | Sep 2026 |
| Cigna Investments Inc | 3.44M | 5.56% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.80M | 4.52% | +90.96% | Jun 2026 |
| FMR Inc | 2.78M | 4.48% | -15.61% | Jun 2026 |
| BlackRock Inc | 2.22M | 3.58% | +16.67% | Jun 2026 |
| Vanguard Capital Management, LLC | 1.93M | 3.11% | +6.50% | Jun 2026 |
| Millennium Management LLC | 1.72M | 2.78% | +56.17% | Jun 2026 |
| Loomis, Sayles & Company LP | 1.60M | 2.58% | -6.66% | Jun 2026 |
| Acadian Asset Management LLC | 1.25M | 2.02% | +294.00% | Sep 2026 |
| D. E. Shaw & Co LP | 1.20M | 1.94% | +675.56% | Jun 2026 |
| Oberweis Asset Management Inc | 1.05M | 1.69% | 0.00% | Jun 2026 |
| Nuveen, LLC | 951K | 1.53% | +2,309.34% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 844K | 1.36% | +826.79% | Jun 2026 |
| Archon Capital Management LLC | 791K | 1.28% | +9.08% | Jun 2026 |
| Perceptive Advisors LLC | 786K | 1.27% | 0.00% | Jun 2026 |
| Jefferies Financial Group Inc | 684K | 1.10% | -15.44% | Jun 2026 |
| State Street Corp | 611K | 0.99% | +11.41% | Jun 2026 |
| Point72 Asset Management, L.P. | 598K | 0.96% | -34.01% | Jun 2026 |
Omada Health, Inc. Common Stock company profile
- Company name
- Omada Health, Inc. Common Stock
- Ticker
- OMDA.US
- Exchange
- USA Stocks
- Listed since
- Jun 6, 2025
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 980
- Fiscal year end
- December
- Address
- 611 Gateway Blvd, South San Francisco, CA, United States, 94080
- Phone
- 888 987 8337
- Website
- omadahealth.com
About Omada Health, Inc. Common Stock
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Omada Health, Inc. Common Stock management
10- Mr. Sean P. DuffyCo-Founder, CEO & Director · born 1984
- Mr. Wei-Li ShaoPresident · born 1971
- Mr. Steven L. CookChief Financial Officer · born 1986
- Ms. Lauren FixSenior Vice President of Corporate Strategy & Operations
- Mr. Craig GraceyChief Accounting Officer · born 1991
- Mr. Sunil KayitiChief Technology Officer
- Mr. Nathan SalhaGeneral Counsel
- Ms. Nancy VitaleChief People Officer · born 1971
- Ms. Jennifer BeckerChief Care Delivery Operating Officer
- Mr. William DoughertyChief Information Security Officer